ASSURE Wearable Cardioverter Defibrillator (WCD) System
Kestra Medical Technologies, Inc. · Decision date Mar 6, 2026
What did the FDA approve?
FDA records P200037/S018 as a supplement to PMA P200037, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Mar 6, 2026.
FDA approval order statement
approval of software version 5.1.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 6, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P200037/S018
- Regulatory pathway
- PMA supplement
- Applicant
- Kestra Medical Technologies, Inc.
- Product code
- MVK
- Decision code
- APPR
- Decision date
- Mar 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wearable automated external defibrillator.
- Applicant
- Kestra Medical Technologies, Inc.
- Product code
- MVK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200037. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200037 · Original PMA
ASSURE Wearable Cardioverter Defibrillator (WCD) System
P200037/S017 · Related supplement
ASSURE Wearable Cardioverter Defibrillator (WCD) System
P200037/S018 received
Application receipt date recorded by FDA.
P200037/S018 · FDA decision
Normal 180 Day Track
P200037/S019 · Related supplement
ASSURE Wearable Cardioverter Defibrillator (WCD) System
P200037/S020 · Related supplement
ASSURE Wearable Cardioverter Defibrillator system (ASSURE system)
P200037/S021 · Related supplement
ASSURE Wearable Cardioverter Defibrillator (WCD) System
P200037/S022 · Related supplement
ASSURE Wearable Cardioverter Defibrillator (WCD) System
Timeline entries are records held by MedtechLedger for P200037. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200037
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Kestra Medical Technologies, Inc. | PMA approval | Jul 27, 2021 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Jul 22, 2025 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Apr 14, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Jul 16, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Sep 28, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code MVK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LifeVest Wearable DefibrillatorP010030/S205 | Zoll Manufacturing Corporation | PMA supplement | Oct 6, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S204 | Zoll Manufacturing Corporation | PMA supplement | Oct 5, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S203 | Zoll Manufacturing Corporation | PMA supplement | Sep 29, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S201 | Zoll Manufacturing Corporation | PMA supplement | Sep 9, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S202 | Zoll Manufacturing Corporation | PMA supplement | Jul 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Kestra Medical Technologies, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 3933 Lake Washington Blvd. NE, Suite 200, Kirkland, WA, 98033
Sources and methodology
- Original FDA record: P200037/S018
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




